Iovance Biotherapeutics (IOVA) Exchange Rate Effect (2023 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Exchange Rate Effect of -$213000.0 for Q1 2026, down 141.93% year-over-year from $508000.0 in Q1 2025, and down 136.92% quarter-over-quarter from $577000.0 in Q4 2025.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Exchange Rate Effect for 4 consecutive years, with -$213000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 141.93% year-over-year to -$213000.0; the TTM figure through Mar 2026 stood at $423000.0 (down 7.64% YoY), while the FY2025 annual figure was $1.1 million, up 311.46% from the prior year.
- Exchange Rate Effect declined to -$213000.0 in Q1 2026 per IOVA's latest filing, from $577000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $3.0 million in Q4 2023 and bottomed at -$3.8 million in Q2 2023.
- Historically, Exchange Rate Effect has averaged -$195833.3 across 4 years, with a median of -$169000.0 in 2024.
- On a YoY basis, Exchange Rate Effect climbed as much as 691.2% in 2025 and fell as far as 154.27% in 2025.
- Iovance Biotherapeutics' Exchange Rate Effect stood at $3.0 million in 2023, then plunged by 138.99% to -$1.2 million in 2024, then soared by 148.98% to $577000.0 in 2025, then sank by 136.92% to -$213000.0 in 2026.
- Business Quant data shows IOVA's Exchange Rate Effect at -$213000.0 in Q1 2026, $577000.0 in Q4 2025, and -$680000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Iovance Biotherapeutics | 3.95 Bn | 3.66 Bn | 55.72 Mn | -124,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -124,000.00 |
| Mar 31, 2026 | -213,000.00 |
| Dec 31, 2025 | 577,000.00 |
| Sep 30, 2025 | -680,000.00 |
| Jun 30, 2025 | 739,000.00 |
| Mar 31, 2025 | 508,000.00 |
| Dec 31, 2024 | -1.18 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | -125,000.00 |
| Mar 31, 2024 | -491,000.00 |
| Dec 31, 2023 | 3.02 Mn |
| Sep 30, 2023 | -1.99 Mn |
| Jun 30, 2023 | -3.77 Mn |